Kobo Biotech Ltd

AI
Kobo Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Kobo Biotech Ltd

₹ 4.90 -2.00%
08 Sep - close price
avonlifesciences.com BSE: 531541
About

Incorporated in 1993, Kobo Biotech Ltd is in the pharmaceutical business[1]

Key Points

Business Overview:[1]
KBL manufactures Active Pharmaceutical Ingredients based on Fermentation technology. Its manufacturing facility is located in Solapur, Maharashtra, spread over 21 acres

Website BSE
  • Market Cap ₹ 11.7 Cr.
  • Current Price ₹ 4.90
  • High / Low ₹ 9.99 / 1.99
  • Stock P/E
  • Book Value ₹ -58.0
  • Dividend Yield 0.00 %
  • ROCE -126 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.27 0.70 0.30 9.24 0.34 0.21 0.17 0.79 0.23 0.20 0.20 0.25 0.34
Operating Profit -0.27 -0.70 -0.30 -9.24 -0.34 -0.21 -0.17 -0.79 -0.23 -0.20 -0.20 -0.25 -0.34
OPM %
0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02
Interest 0.00 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 1.35 1.03 1.04 1.18 1.15 0.89 1.03 1.00 1.01 1.02 1.03 1.01 1.01
Profit before tax -1.60 -1.86 -1.34 -10.42 -1.47 -1.10 -1.20 -1.79 -1.22 -1.22 -1.23 -1.26 -1.33
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-1.60 -1.86 -1.35 -10.42 -1.47 -1.10 -1.19 -1.79 -1.23 -1.22 -1.23 -1.26 -1.33
EPS in Rs -0.67 -0.78 -0.57 -4.37 -0.62 -0.46 -0.50 -0.75 -0.52 -0.51 -0.52 -0.53 -0.56
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
56.89 29.05 32.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
61.34 38.51 27.74 4.05 3.02 1.72 0.69 2.79 10.51 1.50 0.88 1.24
Operating Profit -4.45 -9.46 4.80 -4.05 -3.02 -1.72 -0.69 -2.79 -10.51 -1.50 -0.88 -1.24
OPM % -7.82% -32.56% 14.75%
0.18 2.60 0.42 6.00 0.04 -2.15 0.03 0.04 0.02 0.02 0.02 0.08
Interest 18.14 15.62 14.37 14.41 14.50 14.44 14.47 10.84 0.13 0.00 0.00 0.00
Depreciation 9.62 7.78 7.31 6.78 6.44 6.15 5.88 5.64 4.61 4.07 4.07 4.07
Profit before tax -32.03 -30.26 -16.46 -19.24 -23.92 -24.46 -21.01 -19.23 -15.23 -5.55 -4.93 -5.23
Tax % 1.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-32.57 -30.26 -16.46 -19.24 -23.92 -24.46 -21.01 -19.23 -15.23 -5.55 -4.93 -5.23
EPS in Rs -14.48 -13.45 -6.94 -8.08 -10.04 -10.27 -8.82 -8.07 -6.39 -2.33 -2.07 -2.20
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: 6%
5 Years: 12%
3 Years: 18%
TTM: -6%
Stock Price CAGR
10 Years: -4%
5 Years: 2%
3 Years: 19%
1 Year: 115%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 22.50 22.50 23.73 23.83 23.83 23.83 23.83 23.83 23.83 23.83 23.83 23.83
Reserves 22.07 -8.83 -17.30 -42.41 -66.33 -90.79 -111.80 -131.03 -146.25 -151.81 -156.74 -161.97
136.99 142.42 152.68 207.60 221.96 236.36 250.76 260.53 140.71 139.84 139.69 139.69
97.45 95.74 101.36 63.20 66.48 70.04 73.54 77.26 60.89 63.47 64.62 70.04
Total Liabilities 279.01 251.83 260.47 252.22 245.94 239.44 236.33 230.59 79.18 75.33 71.40 71.59
103.52 95.10 87.79 81.01 74.56 68.42 62.54 56.91 41.66 37.59 33.52 29.44
CWIP 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25 0.00 0.00 0.00 0.00
Investments 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 0.00 0.00 0.00 0.00
161.05 142.29 158.24 156.77 156.94 156.58 159.35 159.24 37.52 37.74 37.88 42.15
Total Assets 279.01 251.83 260.47 252.22 245.94 239.44 236.33 230.59 79.18 75.33 71.40 71.59

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
11.02 19.32 5.62 32.30 31.47 20.95 14.48 2.51 93.76 0.87 0.20 4.18
-4.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25.09 0.00 0.00 0.00
-7.00 -20.50 -5.27 -32.76 -31.47 -20.95 -14.47 -1.08 -120.28 -0.87 -0.15 0.00
Net Cash Flow -0.69 -1.18 0.35 -0.46 0.00 0.00 0.00 1.43 -1.43 0.00 0.05 4.18
Free Cash Flow 6.31 19.32 5.62 32.30 31.47 20.95 14.48 2.51 106.65 0.87 0.20 4.18
CFO/OP -260% -204% 117% -798% -1,042% -1,218% -2,099% -90% -892% -58% -23% -337%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 419.02 705.62 1,006.50
Inventory Days 585.06 896.42 1,038.63
Days Payable 404.72 659.54 1,092.57
Cash Conversion Cycle 599.37 942.51 952.56
Working Capital Days 26.63 -276.67 -251.48
ROCE % -7.12% -10.18% -1.33% -2.77% -5.11% -4.49% -3.94% -5.31% -17.60% -36.82% -52.90% -125.57%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Export Share of Total Revenue
% of total revenue

Log in to view insights

Please log in to see hidden values.

Login
Number of Operational Manufacturing Plants
plants
USFDA EIR Valid Status
binary (1=valid, 0=not valid/not disclosed)
WIP as % of Total Inventory
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

7 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95%
0.66% 0.66% 0.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
54.39% 54.37% 54.39% 55.06% 55.05% 55.05% 55.04% 55.05% 55.05% 55.05% 55.05% 55.05%
No. of Shareholders 6,4786,5306,7676,7886,9167,5427,8737,9297,9477,9707,9777,734

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports